v3.21.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 14,223,917 $ 1,516,272
Accounts receivable, net 1,080,656 1,710,665
Prepaid expenses and other current assets 415,915 519,063
Inventories, net 2,420,179 1,620,509
Advances on contracts 414,202 710,662
Total current assets 18,554,869 6,077,171
Furniture, fixtures and equipment, net 30,729 44,976
Intangibles, net 329,249 382,260
Right of use assets 632,453 15,977
Other assets 24,150 35,905
Total assets 19,571,450 6,556,289
Current liabilities:    
Accounts payable 482,972 1,379,425
Accounts payable, related party 385,138 1,358,752
Accrued expenses and other payables 824,454 775,055
Accrued expenses, related party 586,734 1,057,957
Current portion of finance leases liabilities 7,796 3,904
Current portion of operating lease right-of-use liabilities 72,031 12,073
Deferred profit, related party 242,589 340,476
Note payable 276,180
Total current liabilities 2,877,894 4,927,642
Finance lease liabilities 28,607
Operating lease liabilities 557,981
Total liabilities 3,464,482 4,927,642
Commitments and contingencies
Stockholders’ equity    
Common stock, par value $.001; authorized 85,000,000 shares; 64,171,435 shares issued and 64,138,102 shares outstanding as of December 31, 2020; 49,410,176 shares issued and 49,376,843 shares outstanding as of December 31, 2019; 64,171 49,410
Additional paid in capital 117,934,696 96,082,324
Accumulated deficit (100,885,957) (93,524,297)
Treasury stock, at cost, 33,333 shares (911,516) (911,516)
Total Milestone Scientific Inc. stockholders' equity 16,201,394 1,695,921
Noncontrolling interest (94,426) (67,274)
Total stockholders’ equity 16,106,968 1,628,647
Total liabilities and stockholders’ equity $ 19,571,450 $ 6,556,289

Source